CochLear (OTCMKTS:CHEOY) Share Price Crosses Above 200 Day Moving Average – Here’s Why

Shares of CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $52.01 and traded as high as $54.00. CochLear shares last traded at $53.09, with a volume of 13,588 shares.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on CHEOY shares. Royal Bank Of Canada lowered shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 target price for the company. in a research report on Thursday, July 16th. Canaccord Genuity Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 18th. Finally, Jefferies Financial Group lowered shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 22nd. Five equities research analysts have rated the stock with a Hold rating. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $117.00.

CochLear Stock Performance

The business has a 50 day simple moving average of $48.22 and a 200-day simple moving average of $52.01.

CochLear Company Profile

Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions for people with moderate to profound hearing loss. Its portfolio includes cochlear implants, bone conduction implants and related sound processors, accessories and connectivity products designed to help users hear in a range of environments.

The company also provides clinical support, rehabilitation resources, software, technical services and ongoing care for recipients, clinicians and hearing professionals.